That’s a good point about patient privacy. On X, you suggested that PEPFAR has had a sizable macro impact on AIDS in Africa. Maybe Africans who are old enough to remember could talk about what AIDS was like in Africa before and after PEPFAR, as a way to illustrate that macro impact without violating the privacy of any individual patients.
Of course, insofar as individual patients are willing to speak about their experiences, possibly with some light anonymization such as looking away from the camera, that seems really good to me too.
A couple other thoughts:
If access to ARV drugs is interrupted, I imagine that could lead to drug-resistant HIV strains, same way your doctor tells you to take your antibiotics consistently.
That’s a good point about patient privacy. On X, you suggested that PEPFAR has had a sizable macro impact on AIDS in Africa. Maybe Africans who are old enough to remember could talk about what AIDS was like in Africa before and after PEPFAR, as a way to illustrate that macro impact without violating the privacy of any individual patients.
Of course, insofar as individual patients are willing to speak about their experiences, possibly with some light anonymization such as looking away from the camera, that seems really good to me too.
A couple other thoughts:
If access to ARV drugs is interrupted, I imagine that could lead to drug-resistant HIV strains, same way your doctor tells you to take your antibiotics consistently.
Having a big population of immunocompromised people in Africa seems bad in terms of mutation speed for future pandemics. Here’s a paper I just found on Google, about COVID variants which are thought to have arisen from immunocompromised patients.